Otis Clapp Ultraprin
- Manufacturer
- Unifirst First Aid Corporation
- Effective date
- 2025-09-09
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 25
- Source
- full-release
- Hydrated at
- 2026-06-01 01:13:09
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
Active ingredient
Ibuprofen 200 mg (NSAID)
*nonsteroidal antinflamatory drug
OTC - PURPOSE SECTION
Purpose
Pain reliever/fever reducer
INDICATIONS & USAGE SECTION
Uses
Temporarily relieves minor aches and pains associated with
■ headache ■ toothache ■ backache ■ menstrual cramps
■ common cold ■ muscular aches ■ minor arthritis pain
Temporarily reduces fever.
WARNINGS SECTION
Warnings
Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
■ hives ■ skin reddening ■ asthma (wheezing) ■ facial swelling ■ rash ■ shock ■ blisters
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
■ are age 60 or older
■ have had stomach ulcers or bleeding problems
■ take a blood thinning (anticoagulant) or steroid drug
■ take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others)
■ have 3 or more alcoholic drinks every day while using this product
■ take more or for a longer time than directed
Heart attack or stroke warning: NSAIDS, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
OTC - DO NOT USE SECTION
Do not use
■ if you have ever had an allergic reaction to any other pain reliever/fever reducer
■ right before or after heart surgery
OTC - ASK DOCTOR SECTION
Ask a doctor before use if
■ you have problems or serious side effects from taking pain relievers or fever reducers
■ stomach bleeding warning applies to you
■ you have a history of stomach problems such as heartburn
■ you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma or had a stroke
■ you are taking a diuretic
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor or pharmacist before use if you are
■ taking aspirin for heart attack or stroke, because ibuprofen may decrease this benefit of aspirin
■ under a doctor’s care for any serious condition
■ taking any other drug
OTC - WHEN USING SECTION
When using this product
■ take with food or milk if stomach upset occurs
OTC - STOP USE SECTION
Stop use and ask a doctor if
■ you experience any of the following signs of stomach bleeding:
■ feel faint ■ vomit blood ■ have bloody or black stools ■ have stomach pain that does not get better
■ you have symptoms of heart problems or stroke
■ chest pain ■ trouble breathing ■ weakness in one part or side of body ■ slurred speech ■ leg swelling
■ pain gets worse or lasts for more than 10 days
■ fever gets worse or lasts for more than 3 days
■ redness or swelling is present in the painful area
■ any new or unexpected symptoms occur
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless specifically directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
■ do not use more than directed
■ the smallest effective dose should be used
■ do not take longer than 10 days, unless directed by a doctor (see Warnings)
Adults and children:(12 years and older)
Take 1 tablet every 4 to 6 hours while symptoms persist. If pain or fever does not respond to 1 tablet, 2 tablets may be used.
Do not exceed 6 tablets in 24 hours, unless directed by a doctor.
Children under 12 years:
Ask a doctor
OTHER SAFETY INFORMATION
Other information
■ read all product information before using
■ store at 68-77°F (20-25°C)
■ avoid excessive heat 104°F (above 40°C )
■ tamper evident sealed packets
■ do not use any opened or torn packets
INACTIVE INGREDIENT SECTION
Inactive ingredients
carnauba wax*, corn starch, hypromellose*, iron oxide red, lactose*, magnesium stearate*, microcrystalline cellulose*, polydextrose*, polyethylene glycol, povidone (K30)*, silicon dioxide, sodium starch glycolate, stearic acid, talc*, titanium dioxide
*may contain
OTC - QUESTIONS SECTION
Questions or comments? 1-800-634-7680
Medi-First Ibuprofen Label
Medi-First®
Ibuprofen 200 mg
100 tablets (50 x 2)
Pain Reliever/Fever Reducer
Aches, Fever • Ibuprofen (NSAID) 200 mg
Pull to Open
Compare active ingredient to:
Advil®
Registered Trademark of Pfizer Consumer Healthcare
This Package is for Households without Young Children.
Tamper Evident Unit Dose Packets
Medi-First Plus Ibuprofen Label
Medi-First® Plus
Ibuprofen
Ibuprofen 200 mg (NSAID)
100 Tablets (50 x 2’s)
Pull To Open
This Package isfor Households without Young Children.
Pain Reliever/Fever Reducer
Compare active ingredient to:
Advil®
Registered Trademark of Pfizer Consumer Healthcare
Tamper Evident Unit Dose Packets
Medique Iprin Label
Medique®
I-Prin
Ibuprofen 200 mg
Anti-Inflammatory (NSAID)
This Package is for Households without Young Children.
Pain Reliever/Fever Reducer • Ibuprofen 200 mg
24 Tablets (12 x 2)
Tamper Evident Unit Dose Packets.
Dover Addaprin Label
Dover Addaprin™
Ibuprofen 200 mg Tablets (NSAID)
Pain Reliever-Fever Reducer
This Package is for Households Without Young Children.
Dover Pharmaceutical
Products of the highest quality and effectiveness
Tamper Evident
Sealed Packets
Unit Dose Packs
500 Tablets
(250 Packets of 2)
Otis Clapp Ultraprin Label
OC Otis Clapp
Quality & Integrity Since 1840
Ultraprin ™
Pain Reliever-Fever Reducer (NSAID)
Ibuprofen Tablets USP 200 mg
For Deep Seated Pain
See Warnings and Directions on Side Panel
Tear Out Along Perforation To Dispense
Professional Healthcare
500 Tablets (250 Packets of 2)
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 900434 | Addaprin 200 MG Oral Tablet | PSN | 25 |
| 310965 | ibuprofen 200 MG Oral Tablet | PSN | 25 |
| 900438 | Ultraprin 200 MG Oral Tablet | PSN | 25 |
| 900434 | ibuprofen 200 MG Oral Tablet [Addaprin] | SBD | 25 |
| 900438 | ibuprofen 200 MG Oral Tablet [Ultraprin] | SBD | 25 |
| 310965 | ibuprofen 200 MG Oral Tablet | SCD | 25 |
| 900434 | Addaprin 200 MG Oral Tablet | SY | 25 |
| 310965 | ibuprofen 200 MG (as ibuprofen sodium 256 MG) Oral Tablet | SY | 25 |
| 900438 | Ultraprin 200 MG Oral Tablet | SY | 25 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| IBUPROFEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47682-700-13 | Medique Iprin | 2 in 1 PACKET | TABLET, COATED | 2 | 25 | |
| 47682-700-13 | Medique Iprin | 250 in 1 BOX | TABLET, COATED | 250 | 25 | |
| 47682-700-47 | Medique Iprin | 2 in 1 PACKET | TABLET, COATED | 2 | 25 | |
| 47682-700-47 | Medique Iprin | 100 in 1 BOX | TABLET, COATED | 100 | 25 | |
| 47682-700-64 | Medique Iprin | 12 in 1 BOX | TABLET, COATED | 12 | 25 | |
| 47682-700-64 | Medique Iprin | 2 in 1 PACKET | TABLET, COATED | 2 | 25 | |
| 47682-700-69 | Medique Iprin | 3 in 1 BOX | TABLET, COATED | 3 | 25 | |
| 47682-700-99 | Medique Iprin | 2 in 1 PACKET | TABLET, COATED | 2 | 25 | |
| 47682-702-13 | Otis Clapp Ultraprin | 250 in 1 BOX | TABLET, COATED | 250 | 25 | |
| 47682-702-99 | Otis Clapp Ultraprin | 2 in 1 PACKET | TABLET, COATED | 2 | 25 | |
| 47682-709-33 | Medi-First Plus Ibuprofen | 50 in 1 BOX | TABLET, COATED | 50 | 25 | |
| 47682-709-33 | Medi-First Plus Ibuprofen | 2 in 1 PACKET | TABLET, COATED | 2 | 25 | |
| 47682-709-48 | Medi-First Plus Ibuprofen | 2 in 1 PACKET | TABLET, COATED | 2 | 25 | |
| 47682-709-48 | Medi-First Plus Ibuprofen | 125 in 1 BOX | TABLET, COATED | 125 | 25 | |
| 47682-714-13 | Dover Addaprin | 250 in 1 BOX | TABLET, COATED | 250 | 25 | |
| 47682-714-99 | Dover Addaprin | 2 in 1 PACKET | TABLET, COATED | 2 | 25 | |
| 47682-718-13 | Medi-First Ibuprofen | 250 in 1 BOX | TABLET, COATED | 250 | 25 | |
| 47682-718-30 | Medi-First Ibuprofen | 2 in 1 PACKET | TABLET, COATED | 2 | 25 | |
| 47682-718-30 | Medi-First Ibuprofen | 4 in 1 BOX | TABLET, COATED | 4 | 25 | |
| 47682-718-33 | Medi-First Ibuprofen | 50 in 1 BOX | TABLET, COATED | 50 | 25 | |
| 47682-718-33 | Medi-First Ibuprofen | 2 in 1 PACKET | TABLET, COATED | 2 | 25 | |
| 47682-718-48 | Medi-First Ibuprofen | 2 in 1 PACKET | TABLET, COATED | 2 | 25 | |
| 47682-718-48 | Medi-First Ibuprofen | 125 in 1 BOX | TABLET, COATED | 125 | 25 | |
| 47682-718-50 | Medi-First Ibuprofen | 25 in 1 BOX | TABLET, COATED | 25 | 25 | |
| 47682-718-50 | Medi-First Ibuprofen | 2 in 1 PACKET | TABLET, COATED | 2 | 25 | |
| 47682-718-99 | Medi-First Ibuprofen | 2 in 1 PACKET | TABLET, COATED | 2 | 25 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| IBUPROFEN | ACTIVE INGREDIENT | WK2XYI10QM | 3 | |
| Ibuprofen | ACTIVE MOIETY | WK2XYI10QM | 3 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 3 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 3 | |
| POVIDONE K30 | INACTIVE INGREDIENT | U725QWY32X | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 3 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 3 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 3 | |
| TRIACETIN | INACTIVE INGREDIENT | XHX3C3X673 | 3 |
Products#
Every source-derived product name is available through these pages.
- Medi-First Ibuprofen
- Ibuprofen
- STARCH, CORN
- POVIDONE K30
- STEARIC ACID
- TITANIUM DIOXIDE
- SODIUM STARCH GLYCOLATE TYPE A POTATO
- SILICON DIOXIDE
- FERRIC OXIDE RED
- TALC
- POLYETHYLENE GLYCOL, UNSPECIFIED
- Medi-First Plus Ibuprofen
- Medique Iprin
- Dover Addaprin
- Otis Clapp Ultraprin
- POLYVINYL ALCOHOL, UNSPECIFIED
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 47682-718 | 47682-718-99, 47682-718-13, 47682-718-48, 47682-718-33, 47682-718-30, 47682-718-50 |
| 47682-709 | 47682-709-48, 47682-709-33 |
| 47682-700 | 47682-700-99, 47682-700-69, 47682-700-64, 47682-700-47, 47682-700-13 |
| 47682-714 | 47682-714-99, 47682-714-13 |
| 47682-702 | 47682-702-99, 47682-702-13 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, COATED / ORAL | 160 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, COATED / ORAL | 1301 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, COATED / ORAL | 160 mg | ||
| TRIACETIN | TRIACETIN | XHX3C3X673 | TABLET, COATED / ORAL | 1 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, COATED / ORAL | 1301 mg | ||
| TRIACETIN | TRIACETIN | XHX3C3X673 | TABLET, COATED / ORAL | 1 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, COATED / ORAL | 1301 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, COATED / ORAL | 160 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, COATED / ORAL | 160 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| TRIACETIN | TRIACETIN | XHX3C3X673 | TABLET, COATED / ORAL | 1 mg | ||
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, COATED / ORAL | 160 mg | ||
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, COATED / ORAL | 160 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| TRIACETIN | TRIACETIN | XHX3C3X673 | TABLET, COATED / ORAL | 1 mg | ||
| TRIACETIN | TRIACETIN | XHX3C3X673 | TABLET, COATED / ORAL | 1 mg | ||
| TRIACETIN | TRIACETIN | XHX3C3X673 | TABLET, COATED / ORAL | 1 mg | ||
| TRIACETIN | TRIACETIN | XHX3C3X673 | TABLET, COATED / ORAL | 1 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, COATED / ORAL | 160 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| TRIACETIN | TRIACETIN | XHX3C3X673 | TABLET, COATED / ORAL | 1 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, COATED / ORAL | 160 mg | ||
| TRIACETIN | TRIACETIN | XHX3C3X673 | TABLET, COATED / ORAL | 1 mg | ||
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, COATED / ORAL | 160 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, COATED / ORAL | 160 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, COATED / ORAL | 1301 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| TRIACETIN | TRIACETIN | XHX3C3X673 | TABLET, COATED / ORAL | 1 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg |
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A079174-001 | IBUPROFEN | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A079174-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2010-12-10 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.




